Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25113324 | 0.89 | LPAR3 (0.44) | LPAR3LPAR2TSHRTRPA1ADORA1 | |
| SCHEMBL3786970 | 0.87 | LPAR3 (0.42) | LPAR3LPAR2TSHRTRPA1ADORA1 | |
| SCHEMBL13345367 | 0.87 | LPAR3 (0.41) | LPAR3LPAR2TSHRTRPA1ADORA1 | |
| SCHEMBL22268773 | 0.79 | TSHR (0.37) | LPAR3LPAR2TSHRALDH1A1LMNA | |
| SCHEMBL19619508 | 0.78 | ALDH1A1 (0.35) | LPAR3LPAR2TSHRADORA1ALDH1A1 | |
| SCHEMBL891891 | 0.78 | LPAR3 (0.52) | LPAR3LPAR2TSHRTRPA1ADORA1 | |
| SCHEMBL2026655 | 0.78 | LPAR3 (0.52) | LPAR3LPAR2TSHRTRPA1ADORA1 | |
| SCHEMBL2027305 | 0.78 | LPAR3 (0.52) | LPAR3LPAR2TSHRTRPA1ADORA1 | |
| SCHEMBL2022487 | 0.78 | LPAR3 (0.52) | LPAR3LPAR2TSHRTRPA1ADORA1 | |
| SCHEMBL2026917 | 0.78 | LPAR3 (0.52) | LPAR3LPAR2TSHRTRPA1ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3331895-B1 | PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF USEFUL AS ANTIVIRAL AGENTS | CHIMERIX INC (US) | 2020-07-29 | — | — | EP | disclosed |